Prothena Corp Public (PRTA) Goodwill & Intangibles (2012 - 2013)
Prothena Corp Public (PRTA) posted quarterly Goodwill & Intangibles of $44000.0 for Q1 2013, down 10.2% quarter-over-quarter from $49000.0 in Q4 2012.
Powered by 
Analysis
Prothena Corp Public (PRTA) Goodwill & Intangibles (2012 - 2013) Analysis & Trends
Prothena Corp Public's Goodwill & Intangibles history runs 2 years deep, the most recent figure standing at $44000.0 for Q1 2013.
- In Q1 2013, Goodwill & Intangibles changed N/A year-over-year to $44000.0; the TTM figure through Mar 2013 stood at $44000.0 (changed N/A YoY), while the FY2012 annual figure was $49000.0, changed N/A from the prior year.
- Goodwill & Intangibles for Q1 2013 stood at $44000.0, down from $49000.0 in the prior quarter.
- The five-year high for Goodwill & Intangibles was $49000.0 in Q4 2012, with the low at $44000.0 in Q1 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 10 | Prothena Corp Public | 509.98 Mn | 221.78 Mn | - |